Oppenheimer adjusted its outlook on Albemarle Corporation (NYSE:ALB), a global developer of lithium and other chemical solutions. The firm's analyst, Colin W. Rusch, reduced the price target to $123 ...

After back-to-back years of 20%-plus gains in 2023 and 2024, the S&P 500 is off to another strong start to 2025. However, the S&P 500's forward earnings multiple of 22 (as of Feb. 7) was also ...

India's Glenmark Pharmaceuticals reported third-quarter profit below estimates on Friday due to bleak U.S. demand for its long-term illness drugs.

Only 14% of security leaders can ‘effectively secure organisational data assets while also enabling the use of data to ...

Manufacturers of medical devices have been benefiting from elevated demand for elective surgical procedures in the United ...

"While some may consider the guide conservative, we believe [Kraft Heinz] will need to make bigger investments in price and quality to bring consumers back to their brands," TD Cowen analysts, led by ...

TELUS Health delivered 10% revenue growth and 20% EBITDA growth in Q4, driven by synergies from the LifeWorks acquisition. The company has achieved $355 million in annualized synergies to date, with a ...